Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12049
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Implications of Model-Informed Drug Discovery and Development for Tuberculosis

Drug Discovery Today
Drug DiscoveryPharmacology
2017English

Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling

Journal of Clinical Pharmacology
Pharmacology
2019English

Good Documentation Practices (GDPs) in Pharmaceutical Industry

Journal of Analytical & Pharmaceutical Research
2017English

Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to PBPK Modeling and Simulation

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2019English

Wiley Series in Drug Discovery and Development

English

Model Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2020English

Regarding the Informed Consent and Its Documentation

Gaceta Medica de Mexico
Medicine
2019English

Application of Genomics and Proteomics in Drug Target Discovery

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2014English

Drug Discovery and Development: The Final Frontier

Prescriber
Pharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy